Skip to content
Newsletter
Toggle navigation
Newsletter
Search for:
Search
About Parkinson's
Toggle menu
What is Parkinson’s disease?
Causes
Diagnosis
Symptoms
Motor symptoms
Non-motor symptoms
Living with Parkinson’s
Types
Treatments
Approved treatments
Experimental treatments
Non-drug treatments
Expert voices
Toggle menu
Integrative medicine
Deep brain stimulation
Safe exercise
Cannabis and Parkinson’s symptoms
Speech difficulties
Diet and nutrition
Caring for mental health
Managing sex and intimacy issues
Parkinson's psychosis guide
Toggle menu
Patients
What is psychosis?
Talking to your doctor about psychosis
Perspective: Living with psychosis
Emotional and mental health
Psychosis risk factors
Caregivers of spouses
Early signs of psychosis
Preparing for psychosis
Perspective: Supporting your spouse
Respite care
Hallucinations, delusions, illusions
Caregivers of parents
Talking to a parent with psychosis
Psychosis care options
Perspective: Caring for a parent
Do’s and don’ts
Remote Parkinson’s care
In focus video series
Managing Parkinson’s psychosis
Strategies for managing psychosis
Early signs of psychosis
Discerning Parkinson's-related psychosis
News & Research
Columns
Toggle menu
The Bright Side
– Jamie Askari
Living My Best Life
– Christine Scheer
The Love Factor
– Chukwuemeka Uchebuakor
PD: The WE Journey
– Jill Hammergren
The Impatient Patient
– Doc Irish
Shaking Things Up
— Mary Beth Skylis
Unshakable Optimist
– Mollie Lombardi
Archived columns
Embrace the Shake
— Samantha Felder
Life, Lemons, and Lemonade
— Lori DePorter
Possibilities With Parkinson’s
— Dr. C
Resilient: Living Relentlessly
— Jo Gambosi
Forums
Advocacy partners
Search
Close drawer
What can we help you find today?
Search for:
Search
Search
Viatcheslav Vlassov, —
Articles by Viatcheslav Vlassov
Recent Posts
Brain-region stimulation may ease motor symptoms, study finds
Casma to develop CSM-101 as treatment for Parkinson’s
Cognitive changes before DBS not a dementia risk factor in Parkinson’s
Rune Labs, Parkinson’s Foundation to study digital biomarkers
SLEIPNIR clinical trial platform to test 3 Parkinson’s drugs at once
Envelope icon
Subscribe to our newsletter
Get regular updates to your inbox.
Your Email
Subscribe
Leave this field empty if you're human:
